BROOKE WILLIAMS: Open Payments
NPI 1366038424 · LATROBE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 19 payments from 6 companies in 2025. Trend: 2023 $92 · 2024 $43 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $165 |
| Madrigal Pharmaceuticals | 4 | $96 |
| PFIZER INC. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: REZDIFFRA, RINVOQ, SKYRIZI, EOHILIA, LINZESS, XELJANZ, Wegovy, VELSIPITY.
Industry payments across PA — which companies pay providers there.
